首页/数据集/Repurposing SARS-CoV-2 Ligands as Potential Therapeutics Against Human Metapneumovirus

Repurposing SARS-CoV-2 Ligands as Potential Therapeutics Against Human Metapneumovirus

Mendeley Data2026-04-09 收录

药物重定位

抗病毒药物研发

数据链接：

https://data.mendeley.com/datasets/23dp444hgw 数据链接链接失效反馈

官方服务：

资源简介：

Repurposing SARS-CoV-2 Ligands as Potential Therapeutics Against Human Metapneumovirus: The data and code used in this research are provided.

应用场景：

药物重定位

药物虚拟筛选

MTHFR (Methylenetetrahydrofolate reductase) is a pivotal enzyme involved in one-carbon metabolism, which is critical for the proliferation of cancer cells. In line with this, published literature show

NIAID Data Ecosystem80

Chemotext: A Publicly Available Web Server for Mining Drug–Target–Disease Relationships in PubMed

药物-靶点-疾病关系挖掘

药物重定位

Elucidation of the mechanistic relationships between drugs, their targets, and diseases is at the core of modern drug discovery research. Thousands of studies relevant to the drug–target–disease (DTD)

NIAID Data Ecosystem60

A 2 × 2 contingency table.

疾病生物标志物发现

药物重定位

Type 2 diabetes (T2D) is a crucial risk factor for both colorectal cancer (CRC) and hepatocellular carcinoma (HCC). However, so far, there was no study that has investigated common drugs against HCC a

Figshare2025-03-24 更新10

Yellow fever virus is susceptible to sofosbuvir both in vitro and in vivo

药物重定位

黄热病毒抗病毒

Yellow fever virus (YFV) is a member of the Flaviviridae family. In Brazil, yellow fever (YF) cases have increased dramatically in sylvatic areas neighboring urban zones in the last few years. Because

Figshare2019-02-14 更新80

Candidate FDA-approved drugs for COVID-19-related activatory targets.

药物重定位

COVID-19治疗

Candidate FDA-approved drugs for COVID-19-related activatory targets.

NIAID Data Ecosystem20